Claire was just 14 when she was diagnosed with cancer after spotting one sign. Now she's bravely opened up about the ...

Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy ...

Claire received the devastating news she had cancer at the age of 14, now she revealed the impact it's had on her life and ...

A pickleball tournament and silent auction will be held to support the Lindblad family and raise awareness for epithelioid sarcoma.

Hope Pearce, 34, from Essex, was told years ago that she only had months to live; however, she's continuing to fight the odds ...

University of Southampton is leading new immunotherapy research for rhabdomyosarcoma.

The festival, which runs until Feb. 8, features a range of innovative theatrical productions that are performed online, via ...

Sanofi has reported mixed phase 3 data on amlitelimab, further muddying the prospec | Sanofi has reported mixed phase 3 data ...

Fresh data from multiple studies suggest the drug, which Sanofi has billed as a future blockbuster, could be cleared in the U ...

New technology is allowing highly-trained surgeons to make smaller incisions, meaning less narcotics and fewer infections and ...

Amlitelimab, an OX40 ligand–targeting therapy that modulates T-cell-mediated inflammation without causing cell depletion, ...